Search results for "Cardiology"
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
Evidence shifting for cardiac drugs with insect allergies
The cardiovascular benefits of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors must be weighed against anaphylaxis risk in patients with allergy.
https://immattersacp.org/archives/2022/04/evidence-shifting-for-cardiac-drugs-with-insect-allergies.htm
1 Apr 2022
ACC updates decision pathway on nonstatin drugs in ASCVD
Experts considered evidence from the FOURIER trial and the SPIRE-1 and SPIRE-2 trials, as well as evidence on addition of ezetimibe to statin therapy after acute coronary syndrome.
https://immattersacp.org/weekly/archives/2017/09/12/1.htm
12 Sep 2017
NOACs recommended instead of warfarin for some afib patients, guideline states
An updated guideline on atrial fibrillation responds to new evidence, as well as the advent of new drugs and devices to treat the condition.
https://immattersacp.org/weekly/archives/2019/02/05/2.htm
5 Feb 2019
New guideline recommends low-dose aspirin for many fewer patients
Changes to the American College of Cardiology/American Heart Association guideline include no longer routinely giving low-dose aspirin for primary prevention to adults older than age 70 years or to younger patients who are not at high risk.
https://immattersacp.org/weekly/archives/2019/03/26/1.htm
26 Mar 2019
Discussing lifetime vs. 10-year CVD risk estimates led to higher patient risk perception, willingness for therapy
Patients who were presented with cardiovascular disease (CVD) risk information using a pictogram had lower perception of risk and were less willing to consider therapy than those presented with a bar graph or no graphic at all.
https://immattersacp.org/weekly/archives/2018/11/13/1.htm
13 Nov 2018
COVID-19 studies look at transmission, cardiac effects, and lung ultrasound as triage
A review found most transmission to be respiratory, while a study suggested protection from eyeglasses. Data from athletes provided insight into cardiac effects, and lung ultrasound may be useful for triage. Philip A. Masters, MD, FACP, looked at how the pandemic has altered medicine.
https://immattersacp.org/weekly/archives/2020/09/22/1.htm
22 Sep 2020
Observe, listen, feel: Going back to Osler
These three skills hold enormous opportunity to strengthen physicians' diagnostic acumen.
https://immattersacp.org/archives/2022/03/observe-listen-feel-going-back-to-osler.htm
1 Mar 2022
MKSAP Quiz: Risk assessment in a healthy patient
A 45-year-old man is evaluated during a routine visit. He reports no symptoms, and his medical and family history are unremarkable. Following a physical exam, what is the most appropriate cardiovascular disease assessment?
https://immattersacp.org/weekly/archives/2023/09/05/3.htm
5 Sep 2023
Age only one consideration in post-MI drug therapy
To determine the best therapy for elderly patients after a heart attack, physicians should get to know their goals for their lives.
https://immattersacp.org/archives/2020/09/age-only-one-consideration-in-post-mi-drug-therapy.htm
1 Sep 2020